Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel ...

Biomedical engineers use iPSCs to grow specialized retinal endothelial cells, successfully regenerating damaged eye blood ...

Memento Medicines, a privately held biotech developing biologic therapies for retinal disease, has launched with a $93 ...

The retina, as a highly specialized and metabolically demanding neural tissue, is vulnerable to a wide spectrum of debilitating disorders — including ...

New trial data show aflibercept 8 mg and faricimab extend dosing to 16–20 weeks in AMD, DME, RVO while maintaining safety.

Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel cells critical to retinal health for the first time. When injected into mouse ...

Blind people have been offered fresh hope of seeing again after lab-grown cells restored retinal function in mice. The ...

Population-based studies have shown retinal disorders are the most common cause of irreversible blindness in developed countries and the second most common cause of blindness after cataracts in ...

Sunir Garg, MD, expresses excitement about attending AAO 2025 and focuses on several topics to be discussed. These include the benefits and potential vision risks of GLP-1 inhibitors in patients with ...

Preclinical study showed iRECs Integrated into host vascular network and revascularized the ischemic eye, rescuing the tissue.

It could 'pave the way for new therapeutic approaches.' ...